Neoseptolete Combi Citron A Zázvor (Benzydamine Hydrochloride, Cetylpyridinium Chloride)

Benzydamine hydrochloride exerts anti‑inflammatory, analgesic and mild anaesthetic effects by inhibiting the release of pro‑inflammatory cytokines and stabilising cell membranes in the oral mucosa. This reduces pain and swelling at the site of application.

The appropriate dose of Neoseptolete Combi Citron A Zázvor is determined by the prescribing healthcare professional based on the patient’s age, condition severity and clinical response. Patients should follow the prescriber’s instructions and the product label.

Safety data for benzydamine hydrochloride and cetylpyridinium chloride in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the product.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Neoseptolete combines benzydamine hydrochloride, a locally acting NSAID, with cetylpyridinium chloride, an antiseptic. This dual action offers both anti‑inflammatory relief and antimicrobial activity, which distinguishes it from single‑ingredient products that may only address pain or only provide antiseptic effects.

Store the product at ambient temperature, preferably below 25 °C. Keep it in the original container, protect it from moisture and direct sunlight, and ensure the cap is tightly closed to maintain product stability.

Neoseptolete is intended for oral use. The prescribed amount is applied directly to the affected area of the mouth, such as the throat or ulcer, and may be swished or held briefly before expectorating, following the healthcare professional’s directions.

Serious risks, though rare, include allergic reactions like rash, swelling, or difficulty breathing, and severe oral ulceration or tissue necrosis. Any signs of an allergic response or worsening oral lesions should prompt immediate medical attention.

Individuals with known hypersensitivity to benzydamine hydrochloride, cetylpyridinium chloride, or any excipients in the formulation should avoid using the product. Patients with uncontrolled oral infections or severe mucosal damage should consult a clinician before use.